Literature DB >> 21507976

Opposing effects of CD70 costimulation during acute and chronic lymphocytic choriomeningitis virus infection of mice.

Pablo Penaloza-MacMaster1, Ata Ur Rasheed, Smita S Iyer, Hideo Yagita, Bruce R Blazar, Rafi Ahmed.   

Abstract

T cell costimulation is important for T cell activation. The CD27/CD70 pathway contributes to effector and memory T cell development and is involved in T cell and B cell activation. CD27/CD70 is known for having opposing roles during different models of antigenic challenges. During primary T cell responses to influenza virus infection or during tumor challenges, CD27/CD70 costimulation has a positive role on T cell responses. However, during some chronic infections, constitutive triggering of this signaling pathway has a negative role on T cell responses. It is currently unclear what specific characteristic of an antigen determines the outcome of CD27/CD70 costimulation. We investigated the effect of a transient CD70 blockade during an acute or a chronic lymphocytic choriomeningitis virus (LCMV) infection in mice. Blockade of this pathway during acute LCMV infection (Armstrong strain) resulted in delayed T cell responses and decreased CD127 (interleukin-7 receptor α [IL-7Rα] chain) conversion. Upregulation of CD127 is an important event in T cell differentiation that heralds the passage of an effector T cell to a long-lived memory T cell. In contrast to the reduced CD8 T cell responses after CD70 blockade during acute infection, CD70 blockade during chronic LCMV infection resulted in increased CD8 T cell responses. Our data show the dual roles of this costimulatory pathway in acute versus persistent antigen challenge. Our findings suggest that antigen persistence may determine the effect of CD27/CD70 signaling on CD8 T cell responses. Tailored triggering or blockade of this costimulatory pathway may be important in vaccination regimens against acute or chronic pathogens.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507976      PMCID: PMC3126534          DOI: 10.1128/JVI.02205-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  The B7-CD28 superfamily.

Authors:  Arlene H Sharpe; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

2.  Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions.

Authors:  Kiki Tesselaar; Ramon Arens; Gijs M W van Schijndel; Paul A Baars; Martin A van der Valk; Jannie Borst; Marinus H J van Oers; René A W van Lier
Journal:  Nat Immunol       Date:  2002-12-09       Impact factor: 25.606

Review 3.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice.

Authors:  Shahram Salek-Ardakani; Rachel Flynn; Ramon Arens; Hideo Yagita; Geoffrey L Smith; Jannie Borst; Stephen P Schoenberger; Michael Croft
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

5.  Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions.

Authors:  A I Chen; A J McAdam; J E Buhlmann; S Scott; M L Lupher; E A Greenfield; P R Baum; W C Fanslow; D M Calderhead; G J Freeman; A H Sharpe
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

6.  Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion.

Authors:  R Arens; K Tesselaar; P A Baars; G M van Schijndel; J Hendriks; S T Pals; P Krimpenfort; J Borst; M H van Oers; R A van Lier
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

7.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Involvement of CD70 and CD80 intracytoplasmic domains in the co-stimulatory signal required to provide an antitumor immune response.

Authors:  Victorine Douin-Echinard; Jean-Marie Péron; Valérie Lauwers-Cancès; Gilles Favre; Bettina Couderc
Journal:  Int Immunol       Date:  2003-03       Impact factor: 4.823

9.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

10.  CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool.

Authors:  Jenny Hendriks; Yanling Xiao; Jannie Borst
Journal:  J Exp Med       Date:  2003-10-27       Impact factor: 14.307

View more
  28 in total

1.  Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity.

Authors:  Suzanne P M Welten; Anke Redeker; René E M Toes; Ramon Arens
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  A novel anti-HIV immunotherapy to cure HIV.

Authors:  Ali Ahmad; Charles R Rinaldo
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

3.  Regulation of tissue-dependent differences in CD8+ T cell apoptosis during viral infection.

Authors:  Varun N Kapoor; Hyun Mu Shin; Ok Hyun Cho; Leslie J Berg; Joonsoo Kang; Raymond M Welsh
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

4.  TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma.

Authors:  Z-Z Yang; D M Grote; B Xiu; S C Ziesmer; T L Price-Troska; L S Hodge; D M Yates; A J Novak; S M Ansell
Journal:  Leukemia       Date:  2014-02-26       Impact factor: 11.528

5.  Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens.

Authors:  Pablo Penaloza-MacMaster; Jeffrey E Teigler; Rebecca C Obeng; Zi H Kang; Nicholas M Provine; Lily Parenteau; Stephen Blackmore; Joshua Ra; Erica N Borducchi; Dan H Barouch
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

Review 6.  TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

Review 7.  Co-stimulatory and co-inhibitory pathways in cancer immunotherapy.

Authors:  Rachel E O'Neill; Xuefang Cao
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

8.  OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence.

Authors:  Sarah Buchan; Teresa Manzo; Barry Flutter; Anne Rogel; Noha Edwards; Lei Zhang; Shivajanani Sivakumaran; Sara Ghorashian; Ben Carpenter; Clare Bennett; Gordon J Freeman; Megan Sykes; Michael Croft; Aymen Al-Shamkhani; Ronjon Chakraverty
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

9.  Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.

Authors:  Jeffrey J Teoh; Awndre E Gamache; Alyssa L Gillespie; Michael D Stadnisky; Hideo Yagita; Timothy N J Bullock; Michael G Brown
Journal:  J Immunol       Date:  2016-10-24       Impact factor: 5.422

10.  Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma.

Authors:  Qiong J Wang; Ken-Ichi Hanada; Paul F Robbins; Yong F Li; James C Yang
Journal:  Cancer Res       Date:  2012-10-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.